Here is your daily news to keep you well-informed:

Hospitals & Healthcare

• Readmission rates higher with chronic conditions
• Insulin Resistance May Lead to Kidney Disease in the Elderly: Study
• Study suggests breakthrough in organ transplants
• Rheumatoid Arthritis May Raise Risk of Heart Rhythm Disorder
• 'Personalized Medicine' Hits a Bump

• Adding Second Drug No Help in Alzheimer's
• Could a NOSH-Aspirin-A-Day Keep Cancer Away?
• Study suggests overall benefit from antidepressants

• Doctors using compounding pharmacies to cope with anesthesia drug shortage

1. Readmission rates higher with chronic conditions
   Hospital readmission rates for chronic conditions are substantially higher than rehospitalizations for acute conditions, regardless of payer or age group, the Agency for Healthcare Research and Quality (AHRQ) announced.
   Fierce Healthcare
   
   
2. Insulin Resistance May Lead to Kidney Disease in the Elderly: Study
   Elderly people with metabolic syndrome are at increased risk for chronic kidney disease, and insulin resistance may be the central hub that links metabolic syndrome and kidney-function decline, according to a new study.
   HealthDay
   
   
3. Study suggests breakthrough in organ transplants
   A small pilot study indicates that following up an imperfectly matched organ transplant with an infusion of the donor's stem cells may free recipients from a lifetime of anti-rejection drugs.
   The Los Angeles Times
   
   
4. Rheumatoid Arthritis May Raise Risk of Heart Rhythm Disorder
   People with rheumatoid arthritis (RA) are at increased risk for a heart rhythm disorder called atrial fibrillation, a new study finds.
   HealthDay
   
   

---



---

5. 'Personalized Medicine' Hits a Bump
   A tumor's genetic makeup can vary significantly even within the same tumor sample, researchers said, a finding that poses new challenges to the personalized-medicine movement in cancer.
   The Wall Street Journal
   
   

1. Adding Second Drug No Help in Alzheimer's
   For patients with moderate-to-severe Alzheimer's disease, continuing treatment with donepezil -- a cholinesterase inhibitor -- has some benefits, but adding memantine (Namenda) does not, a randomized trial showed.
   MedPage Today
   
   
2. Could a NOSH-Aspirin-A-Day Keep Cancer Away?
   The humble aspirin may soon have a new role. Scientists from The City College of New York have developed a new aspirin compound that has great promise to be not only an extremely potent cancer-fighter, but even safer than the classic medicine cabinet staple.
   Science Daily
   
   
3. Study suggests overall benefit from antidepressants
   Despite recent debate about how well antidepressants really work in people with only mild or moderate depression, a new analysis of drug studies suggests they may have some benefit across the board.
   Reuters
   
   

1. Doctors using compounding pharmacies to cope with anesthesia drug shortage
   Across the country, doctors who use anesthesia drugs are opening up their medicine cabinets to find them nearly empty. The FDA is reporting a shortage of nearly 283 drugs.
   Today's THV
   
   

PharmacyOneSource.com Privacy Policy
Pharmacy OneSource, 7780 Elmwood Ave. Ste #210 Middleton, WI 53562
Phone: (800) 654-8395